LEP-ETU
Term · Oncology and biomedicine · MLC-T-ONC-004779
A form of the anticancer drug paclitaxel that is contained in very tiny, fat-like particles. It may have fewer side effects and work better than paclitaxel. It is being studied in the treatment of several types of cancer. LEP-ETU blocks the ability of cells to divide and may kill cancer cells. It is a type of mitotic inhibitor and a type of antimicrotubule agent. Also called liposomal paclitaxel, LipoTaxen, paclitaxel liposome, and PNU-93914.
| Identifier | MLC-T-ONC-004779 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | liposomal paclitaxel; LipoTaxen; paclitaxel liposome |
| Synonyms | PNU-93914 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-004779",
"term": "LEP-ETU",
"field": "Oncology and biomedicine",
"definition": "A form of the anticancer drug paclitaxel that is contained in very tiny, fat-like particles. It may have fewer side effects and work better than paclitaxel. It is being studied in the treatment of several types of cancer. LEP-ETU blocks the ability of cells to divide and may kill cancer cells. It is a type of mitotic inhibitor and a type of antimicrotubule agent. Also called liposomal paclitaxel, LipoTaxen, paclitaxel liposome, and PNU-93914.",
"expansions": [
"liposomal paclitaxel",
"LipoTaxen",
"paclitaxel liposome"
],
"synonyms": [
"PNU-93914"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/lep-etu/"
}
Record 10,016 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.